# RHYTHM PHARMACEUTICALS INC (RYTM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RYTM/

- Reporting holders: 6
- Reported value: $1.0M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [TOTH FINANCIAL ADVISORY CORP](https://holderbook.com/funds/866780-toth-financial-advisory-corp/) | $742.7K | 7,800 | 0.1% | 6 |
| [ELEVATION WEALTH PARTNERS, LLC](https://holderbook.com/funds/1976256-elevation-wealth-partners-llc/) | $187.7K | 1,971 | 0.1% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $62.8K | 660 | 0.0% | 12 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $46.8K | 492 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $6.3K | 66 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $95 | 1 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $1.0M |
| Q2 2026 | 307 | $9.1B |
| Q1 2026 | 287 | $6.5B |
| Q4 2025 | 282 | $7.9B |
| Q3 2025 | 266 | $7.1B |
| Q2 2025 | 232 | $4.3B |
| Q1 2025 | 233 | $3.5B |
| Q4 2024 | 207 | $3.7B |
| Q3 2024 | 182 | $3.6B |
| Q2 2024 | 168 | $2.9B |
| Q1 2024 | 172 | $3.0B |
| Q4 2023 | 173 | $3.1B |